Efficiency and safety of hepatic arterial infusion chemotherapy (HAIC) combined with anti-PD1 therapy versus HAIC monotherapy for advanced hepatocellular carcinoma: A multicenter propensity score matching analysis.

Yangyang LiWendao LiuJunwei ChenYongxin ChenJiandong GuoHuajin PangWentao ZhangChao AnChengzhi Li

Published in: Cancer medicine (2024)

The combination therapy of HAIC and PD1 inhibitors successfully extended OS to advanced HCC patients and could be a better choice than HAIC monotherapy.

Keyphrases

combination therapy
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
prognostic factors
peritoneal dialysis
open label
randomized controlled trial
clinical trial
stem cells
locally advanced
bone marrow